Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Greyenbuhl’s tenure will begin after Veradigm files reports on the 2023 and 2024 fiscal years, or by May 11.
April 7, 2026
By: Patrick Lavery
Content Marketing Editor
Veradigm, which provides clinical and revenue cycle solutions for independent practices, is naming Christian Greyenbuhl Chief Financial Officer (CFO). Veradigm’s network includes 20,000 provider practices connected to health plans and biopharma via AI-powered data and technology.
Greyenbuhl comes from the software-as-a-service (SaaS)-based technology company Ministry Brands, where he was also CFO. With Ministry Brands, Greyenbuhl had led all aspects of the company’s finance organization dating back to November 2022.
Prior to that, Greyenbuhl was Senior Vice President, Corporate Finance and Investor Relations, at the SaaS-based tech company Xplor Technologies. He served two stints as general manager of businesses at ADP, and also worked for PricewaterhouseCoopers for over a decade.
The date on which Greyenbuhl will assume Veradigm’s CFO role is yet to be determined, according to the company. It could be the first business day after Veradigm files its Fiscal Year 2023–24 Annual Reports on Form 10-K. However, if that happens before May 11, 2026, then May 11 will be Greyenbuhl’s start date. Alternately, Veradigm says, another, alternate agreement could be reached.
Whenever that happens, Greyenbuhl said, he will join a team aiming to deliver more actionable insights across the healthcare ecosystem.
“I am honored to join the Veradigm team at such a pivotal moment,” Greyenbuhl said. “Veradigm has a unique opportunity to leverage its strong market position, differentiated capabilities, and powerful data assets.”
Veradigm CEO Donald Trigg indicated Greyenbuhl’s arrival signals the completion of a team equipped to drive the company’s “strategic reset.”
At Veradigm, Greyenbuhl is succeeding Lee Westerfield, who had been serving as interim CFO. Westerfield will remain with the company in a consulting role, and will assist in a transition of responsibilities.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !